(Q52208717)

27 April 2018

title

Do we need 3 doses of hepatitis B vaccine? (English)

1 reference

27 April 2018

author name string

Wilson JN

series ordinal

1

1 reference

27 April 2018

Nokes DJ

series ordinal

2

1 reference

27 April 2018

language of work or name

English

0 references

publication date

1 June 1999

1 reference

27 April 2018

number of pages

7

1 reference

inferred from page(s)

published in

Vaccine

1 reference

27 April 2018

volume

17

1 reference

27 April 2018

issue

20-21

1 reference

27 April 2018

page(s)

2667-2673

1 reference

27 April 2018

Recombinant yeast hepatitis B vaccine compared with plasma-derived vaccine: immunogenicity and effect of a booster dose

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900029-8

7 January 2021

Immunological memory and protective immunity: understanding their relation

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900029-8

7 January 2021

Antigen presentation by memory B cells: the sting is in the tail.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900029-8

7 January 2021

Modelling T cell memory.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900029-8

7 January 2021

B-cell memory is short-lived in the absence of antigen.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900029-8

7 January 2021

Cytotoxic T-cell memory without antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900029-8

7 January 2021

Quantification of hepatitis B vaccine-induced antibodies as a predictor of anti-HBs persistence

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900029-8

7 January 2021

Differential requirements for survival and proliferation of CD8 naïve or memory T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900029-8

7 January 2021

Maintenance of B-cell memory by long-lived cells generated from proliferating precursors

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900029-8

7 January 2021

Lifespans of naive, memory and effector lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900029-8

7 January 2021

Desirable immunologic characteristics for the development of an ideal vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900029-8

7 January 2021

Scheduling of revaccination against hepatitis B virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900029-8

7 January 2021

Random-effects models, for longitudinal data using Gibbs sampling

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900029-8

7 January 2021

Overview of a 5-year clinical experience with a yeast-derived hepatitis B vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900029-8

7 January 2021

Nine-year follow-up study of a plasma-derived hepatitis B vaccine in a rural African setting

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900029-8

7 January 2021

Immune response to hepatitis B revaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900029-8

7 January 2021

Vaccination against hepatitis B: comparison of three different vaccination schedules

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900029-8

7 January 2021

The hepatitis nucleocapsid as a vaccine carrier moiety

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900029-8

7 January 2021

Efficacy of a high and accelerated dose of hepatitis B vaccine in alcoholic patients: a randomized clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900029-8

7 January 2021

Long-term immunogenicity and efficacy of hepatitis B vaccine in homosexual men

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900029-8

7 January 2021

Passive-active immunisation against hepatitis B: immunogenicity studies in adult Americans

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900029-8

7 January 2021

Five-year follow-up of a prospective randomized trial of hepatitis B recombinant DNA yeast vaccine vs. plasma-derived vaccine in children: Immunogenicity and anamnestic responses

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900029-8

7 January 2021

The need for more aggressive follow-up of children born to hepatitis B surface antigen-positive mothers: lessons from the Louisiana Perinatal Hepatitis B Immunization Program

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900029-8

7 January 2021

Twelve-year follow-up study of hepatitis B immunization of Senegalese infants

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900029-8

7 January 2021

Seven-year study of hepatitis B vaccine efficacy in infants from an endemic area (Senegal).

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900029-8

7 January 2021

The influence of age on the development of the hepatitis B carrier state

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900029-8

7 January 2021

Booster immunization of low- and non-responders after a standard three dose hepatitis B vaccine schedule--results of a post-marketing surveillance.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900029-8

7 January 2021

Hepatitis B vaccine: demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900029-8

7 January 2021

Anti-HBs responses in children vaccinated with different schedules of either plasma-derived or HBV DNA recombinant vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900029-8

7 January 2021

A two-dose hepatitis B vaccine regimen: proof of priming and memory responses in young adults

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900029-8

7 January 2021

Immunogenicity of two doses of yeast recombinant hepatitis B vaccine in healthy older adults.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900029-8

7 January 2021

Antibody responses of adults, adolescents, and children to a plasma-derived hepatitis B vaccine in a rural African setting

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900029-8

7 January 2021

Targeted hepatitis B vaccination--a cost effective immunisation strategy for the UK?

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900029-8

7 January 2021

10.1016/S0264-410X(99)00029-8

Identifiers

DOI

1 reference

27 April 2018

1 reference

27 April 2018